Stay updated on Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5, signaling an updated version of the page rendering. This does not reflect changes to the study details or content.
    Difference
    0.1%
    Check dated 2026-06-05T08:35:35.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed, indicating a software version update on the page. The underlying study content and navigation remain unchanged.
    Difference
    0.1%
    Check dated 2026-05-15T02:10:29.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study record's revision label was updated from v3.5.2 to v3.5.3, indicating a new version of the entry. This update reflects a metadata revision rather than changes to the study content, eligibility, or results.
    Difference
    0.1%
    Check dated 2026-04-30T15:34:10.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:26:55.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision from v3.4.3 to v3.5.0. There are no visible changes to the study details, outcomes, or eligibility criteria on the page.
    Difference
    0.1%
    Check dated 2026-03-25T20:38:36.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:46:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.